ABSTRACT
The Gram-negative oral pathobiont Fusobacterium nucleatum can traverse to extra-oral sites such as placenta and colon, promoting adverse pregnancy outcomes and colorectal cancer, respectively. How this anaerobe sustains many metabolically changing environments enabling its virulence potential remains unclear. Informed by our genome-wide transposon mutagenesis, we report here that the highly conserved Rhodobacter nitrogen-fixation (Rnf) complex, encoded by the rnfCDGEAB gene cluster, is key to fusobacterial metabolic adaptation and virulence. Genetic disruption of the Rnf complex via non-polar, in-frame deletion of rnfC (ΔrnfC) abrogates polymicrobial interaction (or coaggregation) associated with adhesin RadD and biofilm formation. The defect in coaggregation is not due to reduced cell surface of RadD, but rather an increased level of extracellular lysine, which binds RadD and inhibits coaggregation. Indeed, removal of extracellular lysine via washing ΔrnfC cells restores coaggregation, while addition of lysine inhibits this process. These phenotypes mirror that of a mutant (ΔkamA) that fails to metabolize extracellular lysine. Strikingly, the ΔrnfC mutant is defective in ATP production, cell growth, cell morphology, and expression of the enzyme MegL that produces hydrogen sulfide (H2S) from cysteine. Targeted metabolic profiling demonstrated that catabolism of many amino acids, including histidine and lysine, is altered in ΔrnfC cells, thereby reducing production of ATP and metabolites including H2S and butyrate. Most importantly, we show that the ΔrnfC mutant is severely attenuated in a mouse model of preterm birth. The indispensable function of Rnf complex in fusobacterial pathogenesis via modulation of bacterial metabolism makes it an attractive target for developing therapeutic intervention.
IMPORTANCE
This paper illuminates the significant question of how the oral commensal Fusobacterium nucleatum adapts to the metabolically changing environments of several extra-oral sites such as placenta and colon to promote various diseases as an opportunistic pathogen. We demonstrate here that the highly conserved Rhodobacter nitrogen-fixation complex, commonly known as Rnf complex, is key to fusobacterial metabolic adaptation and virulence. Genetic disruption of this Rnf complex causes global defects in polymicrobial interaction, biofilm formation, cell growth and morphology, hydrogen sulfide production, and ATP synthesis. Targeted metabolomic profiling demonstrates that the loss of this respiratory enzyme significantly diminishes catabolism of numerous amino acids, which negatively impacts fusobacterial virulence as tested in a preterm birth model in mice.
KEYWORDS: Fusobacterium nucleatum, Rnf complex, metabolism, hydrogen sulfide, coaggregation, preterm birth, virulence
INTRODUCTION
A prominent member of the human oral microbiota that is known to harbor over 700 bacterial and fungal species (1, 2), the Gram-negative anaerobe Fusobacterium nucleatum plays an integral role in oral biofilm development and dental plaque formation, by virtue of its inherent capacity to adhere to diverse microbial species, notably the Actinomyces spp., Streptococcus spp., Porphyromonas gingivalis, and Candida albicans (3–12). Beyond commensalism, F. nucleatum is also an opportunistic pathogen that can induce preterm birth, promote tumor growth and metastatic progression of breast cancer cells, proliferation and migration of pancreatic cancer cells, and colorectal cancer (CRC), and is noted for its ability to spread from the oral cavity and colonize many extra-oral sites, including placental, breast, pancreatic, and colorectal tissues (13–17). To date, a number of adhesins have been shown to mediate host-pathogen interactions. These include Fap2 and FadA, with the former aiding fusobacterial binding to tumor- and placenta-expressed Gal-GalNAc (18, 19), while the latter promoting placental colonization and CRC progression (17, 20–22). The other known adhesin RadD is a major fusobacterial virulence factor that not only mediates polymicrobial interaction (or coaggregation), a process that is inhibited by arginine and lysine (23, 24), but is also critical for adverse pregnancy outcomes in a mouse model of preterm birth (24).
Recently, a genome-wide Tn5 transposon mutagenesis screen for identifying additional coaggregation factors revealed that the genetic disruption of a lysine metabolic pathway (LMP), e.g., deletion of kamA and kamD genes, blocks coaggregation through the excess accumulation of extracellular lysine, which binds and inhibits RadD (24). The subsequent discovery that the kamA deletion mutant is significantly attenuated in inducing preterm birth in mice (24) led to the realization that amino acid metabolism might play a key role in fusobacterial virulence. Consistent with this, targeted genetic analyses showed that a mutant, ∆megL, defective in cysteine/methionine metabolism leading to decreased hydrogen sulfide (H2S) production, is also attenuated in virulence in the mouse model of preterm birth (25). Yet another set of genes whose disruption by Tn5 insertional mutagenesis obliterated both coaggregation and biofilm development by fusobacteria encodes a putative respiratory enzyme commonly known as the Rnf (Rhodobacter nitrogen-fixation) complex (26).
Originally identified in Rhodobacter capsulatus (27), the Rnf complex is a highly conserved and evolutionarily ancient membrane-bound ferredoxin:NAD+ oxidoreductase that is thought to couple reversible electron transfer from reduced ferredoxin (fdred) to NAD+ with the establishment of an ion-motive force, enabling substrate import and/or ATP biosynthesis (27–29). Found in over 150 bacterial genomes and 2 archaeal genomes, with high occurrence in anaerobes (28), the Rnf complex has been demonstrated to be a multifunctional respiratory enzyme that acts as a versatile metabolic exchange center for nitrogen fixation (27), carbon dioxide fixation (30), metabolism of low-energy substrates, such as ethanol and lactate (31–33), gene regulation to some extent (34, 35), and gut colonization in mice (36). Importantly, whether the Rnf complex contributes to bacterial virulence remains to be explored. Here, we show that F. nucleatum encodes a functional rnf locus, rnfC-rnfD-rnfG-rnfE-rnfA-rnfB, and that genetic disruption of the Rnf complex, via deletion of rnfC or rnfD, causes severe defects in many virulence traits of F. nucleatum, including coaggregation, biofilm formation, H2S production, and ATP production, in addition to altering cell morphology and growth. Intriguingly, while the defect in coaggregation is mechanistically linked to a failure of lysine catabolism, leading to an increased level of extracellular lysine that inhibits RadD-mediated coaggregation, the defects in other traits are attributed to global reduction of amino acid metabolism as determined by targeted metabolomic analysis. Most significantly, the rnfC mutant is severely impaired in inducing preterm birth in mice. This study establishes that the Rnf complex is a central component in F. nucleatum metabolism that broadly impacts bacterial virulence.
RESULTS
Transposon mutagenesis reveals the involvement of the F. nucleatum Rnf complex in biofilm formation, coaggregation, and H2S production
In our previous genome-wide screens that identified F. nucleatum mutants defective in biofilm formation and coaggregation, multiple subunit-encoding genes for the predicted Rnf complex were frequently targeted by Tn5 transposon insertion (24, 26) (Fig. 1A). To establish the potential multifunctional role of the Rnf complex, we further characterized these mutants in standard biofilm and coaggregation assays (24, 26). To cultivate monospecies biofilms, normalized fusobacterial cultures of different strains were seeded into sterile multi-well plates, anaerobically cultured at 37°C for 48 h, and the resultant biofilms were then stained with crystal violet. Compared to the wild-type strain (ATCC 23726), each of the four tested mutant strains were defective in biofilm formation (Fig. 1B). To examine whether these mutants are also deficient in coaggregation, normalized, unwashed fusobacterial cells were mixed and incubated with Streptococcus oralis or Actinomyces oris in a standard assay, followed by imaging (see Materials and Methods). The tested Tn5 mutants also failed to co-aggregate with these two oral co-colonizers at a level similar to that of a radD mutant used as a negative control (Fig. 1C).
Unexpectedly, we noticed that all of the rnf mutants lacked the rotten egg odor characteristically produced by wild-type fusobacteria, suggestive of severe deficiency in hydrogen sulfide production by these mutants. Indeed, in a bismuth sulfide assay, in which bismuth trichloride reacts with H2S to yield precipitation of brown bismuth sulfide, all rnf::Tn5 mutants showed a significantly reduced level of hydrogen sulfide relative to the wild-type strain (Fig. 1D and E). Overall, these results point to a multifaceted role of the Rnf complex in many cellular processes in F. nucleatum.
Genetic deletion of rnfC disrupts RadD-mediated coaggregation via blockage of lysine catabolism
A Tn5 insertion can potentially cause polar effects on transcription of downstream genes. Although this is unlikely the case here (Fig. S1A), we decided to generate non-polar, in-frame deletions of rnf genes utilizing our published protocols (24, 26, 37). Since all Tn5 mutants displayed similar phenotypes, we chose rnfC for further characterizations, as RnfC is predicted to be a peripheral membrane protein, enabling generation of polyclonal antibodies against a recombinant RnfC protein (Fig. S1B). To examine how the Rnf complex mediates polymicrobial interaction, this rnfC mutant (ΔrnfC) and other strains were subjected to the coaggregation assay, in which unwashed fusobacterial cells were mixed with Streptococcus gordonii, like the coaggregation assays done with S. oralis and A. oris as mentioned above (see Fig. 1C). As expected, deletion of rnfC abrogated fusobacterial coaggregation with S. gordonii, as compared to the parent strain (CW1), and this defect was rescued by ectopic expression of RnfC from a plasmid (Fig. 2A; the unwashed panel), supporting the polymicrobial nature of Rnf-associated coaggregation by F. nucleatum that is not limited to S. oralis and A. oris.
Because RadD is essential as the adhesin for fusobacterial coaggregation (23, 24), we examined if deletion of rnfC causes a defect in surface expression of RadD by immunofluorescence microscopy, wherein normalized fusobacterial cells of different strains were stained with antibodies against RadD (α-RadD), followed by counter-staining with Alexa 488-conjugated IgG. Microscopic examination presented in Fig. S2A revealed no significant defects of RadD-surface expression in the ΔrnfC mutant as compared to the parent strain. Consistent with this observation, western blotting of whole-cell lysates showed similar levels of RadD antigen production in all strains—parent, ΔrnfC, and its complement (Fig. S2B). Thus, the coaggregation defect of ΔrnfC is not due to reduced RadD expression.
Unexpectedly, when we utilized ΔrnfC cells free of the culture medium before mixing with S. gordonii, the mutant fusobacteria were able to adhere to oral streptococci at a level comparable to the parent strain (Fig. 2A; compare panels washed vs unwashed). This behavior of sensitivity to the culture medium mirrored that of a deletion mutant of kamA, which is defective in lysine catabolism and hence accumulates excess lysine in the culture medium (24). Given that lysine inhibits RadD-dependent coaggregation (23, 24), the results prompted us to examine the relative extracellular levels of lysine in these strains by using liquid chromatography-mass spectrometry as previously reported (24). Strikingly, compared to the parent strain, the extracellular level of lysine for the ΔrnfC mutant remained high and was quite comparable to that of the ΔkamA mutant (Fig. 2B). Thus, this accumulation of extracellular lysine is likely the inhibitor that blocks coaggregation by ΔrnfC mutant bacteria. To obtain support for this hypothesis, we re-performed the coaggregation assay with the same set of strains in the absence or presence of 15 mM lysine added in the coaggregation mix. Regardless of whether fusobacterial cells were washed or not, the addition of lysine blocked fusobacterial coaggregation with S. gordonii as expected (Fig. 2C).
Since deletion of kamA leads to the accumulation of extracellular lysine (Fig. 2B) (24), we examined the transcript level of kamA in the ΔrnfC mutant by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Remarkably, expression of kamA was significantly reduced in the absence of rnfC, as compared to the parent strain, and this defect was rescued by ectopic expression of rnfC from a plasmid (Fig. S3). In addition, expression of kamD, another lysine metabolic gene in the kamA locus (24), mirrored that of kamA in these strains (Fig. S3). Altogether, the results indicate that the defect of RadD-mediated coaggregation by genetic disruption of rnfC is due to increased extracellular levels of lysine, likely due to the reduced expression of lysine metabolic genes by an as yet unexplored mechanism.
Genetic deletion of rnfC disrupts biofilm formation, growth, cell morphology, and hydrogen sulfide production
Next, to determine how biofilm formation is dependent on the Rnf complex, we first analyzed the non-polar, in-frame rnfC deletion mutant in the aforementioned biofilm assay using crystal violet staining (as described in Fig. 1B above). As expected, this mutant was also unable to form monospecies biofilms compared to the parent strain, and ectopic expression of RnfC on a plasmid was sufficient to restore biofilm formation (Fig. 3A). Since the Rnf complex plays a key role in energy conservation through several bacterial metabolic pathways (27, 38, 39), we reasoned that the defects in biofilm formation by rnf mutants could be due to alterations with respect to fusobacterial physiology. To investigate this further, we tested whether the Rnf complex is important in ATP biosynthesis by subjecting normalized fusobacterial cells to a microbial cell viability assay (BacTiter-Glo), which relies on the mono-oxygenation of luciferin catalyzed by luciferase in the presence of ATP. Indeed, compared to the parent strain, the ΔrnfC mutant drastically reduced ATP production, and complementation with an RnfC-expressing plasmid rescued the defect (Fig. 3B). The ΔrnfC mutant was also severely defective in growth displaying premature growth cessation after the culture reached a suboptimal density (Fig. 3C). Intriguingly, the colony forming units (CFUs) of ΔrnfC cells grown to log phase and harvested for the ATP production assay or grown over the course of 24 h were comparable to that of the parent strain (Fig. S3). This similarity in the CFUs of both parent and ΔrnfC cells grown over time, although the latter shows reduced optical density, might be due to the morphological abnormality of the ΔrnfC mutant with short/stubby cells as examined by electron microscopy (Fig. 3D and E).
Potentially, the physiological deficits reported above might be due to reduced metabolism of amino acids, especially cysteine as it is one of eight important amino acids for fusobacteria (40). To test this hypothesis, we employed the aforementioned bismuth sulfide assay to measure hydrogen sulfide since it is a product of cysteine metabolism in F. nucleatum (25, 41–44). Consistent with the results of our Tn5 mutants, the ΔrnfC mutant showed a significant defect in H2S production, and overexpression of RnfC from a plasmid substantially enhanced this process (Fig. 3F). Because the methionine γ-lyase MegL was previously shown to be responsible for the bulk of H2S production from cysteine metabolism in F. nucleatum (25), we went on to determine the overall expression level of MegL in cells by immunoblotting of whole-cell lysates with antibodies against MegL (α-MegL). Remarkably, compared with the parent and rescued strains, the ΔrnfC mutant expressed a significantly reduced level of MegL (Fig. 3G). This reduction of MegL enzyme corresponded to a reduced level of megL mRNA as determined by qRT-PCR (Fig. S3). Notably, the expression of both cysK1 and cysK2, which encode two additional H2S-producing enzymes (24), was also reduced in the absence of rnfC (Fig. S4).
To ascertain that the physiological defects reported above are a reflection of the loss of Rnf function, we repeated these experiments with a non-polar, in-frame rnfD deletion mutant (ΔrnfD). Like the ΔrnfC mutant, the ΔrnfD mutant showed significant defects in coaggregation, biofilm formation, cell growth, and H2S production, and these defects were rescued by ectopic expression of rnfD (Fig. S5). Altogether, these findings support our hypothesis that the biofilm formation defect caused by genetic disruption of the Rnf complex is not due to defects in cell viability or reduced cell numbers, but rather gross deficiencies in ATP biosynthesis and amino acid metabolism.
Loss of RnfC complex disrupt global F. nucleatum metabolism
To gain further insight into the function of the F. nucleatum Rnf complex in relation to the aforementioned phenotypes associated with genetic disruption of the Rnf complex, we performed metabolomic analysis of parent and ∆rnfC cells using ultra-performance liquid chromatography coupled to mass spectrometry. Among over 80 metabolites detected in these samples, 10 metabolites (Gln, Tyr, Ile, etc.) were elevated, whereas 7 metabolites, including purine ribonucleoside precursors, were significantly depleted in the ∆rnfC mutant, as compared to the parent strain (Fig. 4A).
To obtain a better view of the specific metabolic pathways altered upon loss of rnfC, we performed a quantitative pathway enrichment and pathway topology analysis of the parent and ∆rnfC cell using the free, web-based software, MetaboAnalyst 5.0. In keeping with our initial findings (Fig. 4A), several pathways involved in amino acid and purine metabolism were significantly enriched in the ∆rnfC mutant compared to the parent strain (Fig. 4B and C). Pathway analysis of the “Lys degradation,” “His degradation,” and “Ala/Asp/Gln metabolism” nodes in the topology analysis revealed that many amino acids are directly degraded into glutamate, which is subsequently fermented into the short-chain fatty acids, butyrate, and acetate (Fig. 4D). Significantly, the ∆rnfC mutant had elevated levels of urocanate, glutamine, N-acetyl-L-glutamate, lysine, and the lysine-degradation pathway intermediate, L-2-aminoadipate, relative to the parent strain (Fig. 4E through I), indicating possible disruptions in glutamate fermentation. Consistent with this result, we observed a reduced level of butyrate in this mutant as determined by high-performance liquid chromatography coupled to mass spectrometry (Fig. 4J). Additionally, as demonstrated by pathway analysis of the “Cys/Met metabolism” node from the topology analysis, hydrogen sulfide production is derived primarily from methionine degradation into L-homocysteine and subsequent L-cysteine degradation into pyruvate (Fig. S6A), both catalyzed by MegL (25). Correspondingly, elevated levels of methionine and slightly lower levels of the pathway intermediate, S-adenosyl-L-homocysteine, were observed in the ∆rnfC mutant, relative to the parent strain (Fig. S6B and C), suggesting the Rnf complex may also be important for methionine/cysteine metabolism. In sum, the results support a broad role of the Rnf complex in F. nucleatum metabolism.
The Rnf complex is required for Fusobacterium nucleatum virulence
Because genetic disruption of the Rnf complex causes significant defects in many virulence traits of F. nucleatum (Fig. 1 to 3), we sought to determine whether this complex contributes to F. nucleatum pathogenesis. Utilizing a mouse model of preterm birth as previously reported (24, 37), we infected via tail vein injection groups of five CF-1 pregnant mice at day 16/17 of gestation with roughly 5.0 × 107 CFU of either the parent or ∆rnfC strain, and pup delivery was monitored (Fig. 5A). Strikingly, the ∆rnfC mutant was severely attenuated in virulence, with nearly 50% of pups born alive by the end-point, while almost no pups survived infection by the parent strain within the same timeframe (Fig. 5B). Clearly, the Rnf complex plays a significant role in metabolism that is central to F. nucleatum pathogenesis.
DISCUSSION
The dual life of F. nucleatum as a commensal in the human oral cavity and an opportunistic pathogen in extra-oral sites raises an intriguing question as to how F. nucleatum is able to maintain its plasticity in metabolically changing environments. Here, we have demonstrated that the highly conserved multicomponent Rnf complex plays a central role in mediating metabolism of various amino acids in F. nucleatum, which impacts many physiological traits critical for fusobacterial virulence. Specifically, various rnf mutants emerged in unbiased forward genetic screens in which we sought to uncover genetic factors that govern two different aspects of F. nucleatum pathobiology—its ability to form biofilms and to co-aggregate with certain partner co-colonizers of the oral cavity. We then showed that that targeted disruption of the Rnf complex, via deletion of rnfC or rnfD, not only causes severe defects in coaggregation and biofilm formation but also hydrogen sulfide production, cell morphology and growth, ATP production, and induction of preterm birth (Fig. 1 to 5; Fig. S4).
The ability of fusobacteria to co-aggregate with streptococci and other partners such as A. oris depends on a well-characterized adhesin RadD present on the fusobacterial cell surface. We have shown that the loss of Rnf complex function does not alter RadD expression or its display at the bacterial surface (Fig. S2). Rather, the defect in RadD-mediated interbacterial coaggregation appears to be a consequence of a defect in lysine metabolism mediated by the LMP, which in turn raises the level of extracellular lysine that can bind and inhibit RadD to block coaggregation with oral streptococci and A. oris (Fig. 2). Intriguingly, our results revealed that this reduced lysine metabolism parallels a decreased expression of the LMP genes, i.e., kamA and kamD (Fig. S3). As KamA is predicted to catalyze the conversion of incoming lysine to β-lysine, which is then converted to 3,5-diaminohyxanoate by KamD (24), the reduced level of kamA and kamD caused by rnfC deletion would certainly contribute to the accumulation of extracellular lysine that inhibits coaggregation by binding to and inactivating the adhesin RadD (24). Not only is the ΔrnfC mutant unable to aggregate with oral bacteria, but it is also defective in biofilm formation. Because the viability of ΔrnfC cells remains comparable to the parent strain throughout growth phases (Fig. S3), although the optical density of the former is less than the parent during stationary phase growth (Fig. 3C) likely due to the reduced cell size (Fig. 3D and E), we think that the defect in biofilm formation is a result of defects in metabolism leading to reduced ATP production. It is noteworthy that the growth rate of rnf mutants is similar to that of the parent and complement strains during the early exponential growth before plateauing at the midpoint for the remainder of the growth period (Fig. 3C). It is likely that these mutants are able to utilize available sugars until their exhaustion but unable to metabolize various amino acids.
Consistently, our metabolomic profiling further revealed that the defect in amino acid metabolism is not limited to lysine alone as aforementioned but, rather, the metabolism of many additional amino acids (viz. cysteine, histidine, and glutamate) is also affected (Fig. 4; Fig. S6). Our targeted metabolomic analysis also revealed defects in purine metabolism, which is supported by significant reduction in guanine, adenine, and their respective nucleoside precursors in the absence of rnfC (Fig. 4A through C). Given that F. nucleatum harbors several purine nucleotide biosynthetic pathways originating from many amino acids such as glutamine, glutamate, and/or aspartate, it is likely that the defects in purine metabolism in the ∆rnfC mutant also result from aberrant amino acid utilization. Critically, cysteine metabolism that generates hydrogen sulfide in F. nucleatum is mainly catalyzed by MegL, a conserved L-methionine γ-lyase (25). Logically, we expected that the defective cysteine metabolism in the ∆rnfC mutant would lead to reduced hydrogen sulfide production by the mutant. What we did not anticipate, however, is that the level of hydrogen sulfide production in the ∆rnfC mutant is significantly lower than that of the megL mutant (Fig. 3F), indicating the Rnf complex plays a broader role in amino acid metabolism.
Indeed, pathway and gene expression analyses demonstrated that multiple pathways leading to hydrogen sulfide production are significantly affected in the absence of rnfC (Fig. S6) and that expression of other cysteine metabolic genes, e.g., cysK1 and cysK2, is markedly reduced (Fig. S4). Intriguingly, given CysK1 catalyzes the conversion of cysteine to hydrogen sulfide and L-lanthionine, an essential amino acid required for formation of fusobacterial peptidoglycan (45, 46), the reduced expression of cysK1 by deletion of rnfC can be attributed to aberrant cell growth, short and stumpy cell size, coupled with reduced ATP production (Fig. 3). How the absence of rnfC reduces expression of LMP genes, megL, and cysK1/cysK2 genes remains a significant puzzle. It is noteworthy that the expression of LMP genes and megL is controlled by the two-component transduction systems (TCSs), CarRS and ModRS, respectively (24, 25). One intriguing possibility, which remains to be tested in future studies, is that metabolic blockage by genetic disruption of the Rnf complex causes the accumulation of certain metabolites and intermediates that may trigger gene expression responses from these TCSs and perhaps other transcriptional regulators.
How is the Rnf complex central to F. nucleatum metabolism and virulence? We propose that the F. nucleatum Rnf complex is a versatile metabolic exchange center that promotes metabolism of many amino acids, via the oxidation of reduced ferredoxin to the reduction of NAD+ that generates an electrochemical ion gradient across the cytoplasmic membrane, leading to the formation of several key metabolites and ATP (Fig. 6). In particular, cysteine and methionine are metabolized into H2S and pyruvate. The latter is oxidized to acetyl-CoA, leading to formation of butyryl-CoA and later butyrate, by reduction of ferredoxin (Fdox) and NAD. Electron shuffling from fdred to NAD+ by the Rnf complex generates a sodium/proton gradient that powers the ATP synthase to generate ATP. In addition, the fermentative pathways of many amino acids (His/Lys/Glu/Gln) also lead to crotonyl-CoA that is coupled to reduction of ferrodoxin. As such, genetic disruption of the Rnf complex limits the amino acid fermentative capacity of F. nucleatum causing pleiotropic defects that hinder the virulence capabilities of this pathobiont as seen through defects in coaggregation, biofilm formation, cell morphology and growth, H2S production, ATP biosynthesis, and induction of preterm birth. Given the wide conservation of the Rnf complex in many pathogens and its absence in eukaryotes, this multi-subunit respiratory enzyme may serve as an important target for broad anti-infective therapeutic strategies.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media
The bacterial strains and plasmids used in this study are listed in Table S1. F. nucleatum cells were grown in tryptic soy broth supplemented with 1% Bacto peptone and 0.25% fresh cysteine (TSPC) or on TSPC agar plates in an anaerobic chamber (10% CO2, 10% H2, and 80% N2). Heart infusion broth or heart infusion agar was used to culture A. oris and supplemented with 0.5% glucose to grow S. oralis and S. gordonii. Escherichia coli strains were grown in Luria broth. All bacterial strains, except F. nucleatum, were cultured in a 5% CO2 incubator. When required, chloramphenicol or thiamphenicol were added into the medium at a concentration of 15 µg/mL and 5 µg/mL, respectively. All reagents were purchased from Sigma-Aldrich unless noted otherwise.
Plasmid construction
(i) To generate pRnfC, the primer set com-rnfC-F/R (Table S2) was used to amplify the rnfC coding sequence and its promoter region from chromosomal DNA of F. nucleatum ATCC 23726, while appending the restriction sites KpnI/NdeI to the amplicon (35 cycles at annealing temperature of 55°C). The PCR product was digested with KpnI and NdeI restriction enzymes and cloned into pCWU6 (SI Table S2) precut with the same enzymes. (ii) To generate pRnfD, a segment encompassing the rnfC promoter region and the rnfD coding region was PCR-amplified from chromosomal DNA of F. nucleatum ∆rnfC (35 cycles at 56°C) using the primer set com-rnfD-F/R (Table S2), while appending NdeI and XhoI restriction sites to the amplicon. The PCR product was digested with NdeI and XhoI restriction enzymes and cloned into pCWU6 precut with the same enzymes. (iii) To generate pMCSG7-RnfC, the primer set, LIC-RnfC-F/R, was used to PCR-amplify the rnfC coding sequence from chromosomal DNA of F. nucleatum ATCC 23726, while appending adapter sequences for subsequent ligation-independent cloning into pMCSG7 as previously reported (47). All generated vectors were subjected to DNA sequence to confirm cloned sequences.
Gene deletion in F. nucleatum
Generation of non-polar, in-frame deletion mutants, ΔrnfC and ΔrnfD, was performed according to our published protocol (24, 26, 37), with primers for generation of deletion constructs listed in Table S2. All PCRs were performed with a 55°C annealing temperature for 35 cycles.
qRT-PCR
Overnight-grown (~17 h) fusobacterial cultures were normalized to optical density measurement at 600 nm (OD600) of ~2.0, and cells were harvested by centrifugation for RNA extraction using RNeasy Mini Kits (Qiagen) according to the manufacturer’s instructions, as described previously (25). Approximately 1 µg of purified RNA, free from DNA by treatment with DNase I (Qiagen), was used for cDNA synthesis using iScript RT supermix (Bio-Rad) based on the manufacturer protocol. Real-time PCR reactions were prepared using the SYBR Green PCR Master Mix with the appropriate primers (Table S2), and analysis was performed using the CFX96 Real-Time System (Bio-Rad). The ∆∆CT method was used to calculate changes in gene expression between samples. Briefly, ∆∆CT = ∆CT1 − ∆CT2, where ∆CT = CT (target) − CT (housekeeping gene). Fold changes were calculated as log10(2∆∆Ct). The 16S rRNA gene was used as reference. Reactions without reverse transcriptase were used as control to assess genomic DNA contamination.
Biofilm assay
Stationary-phase (~20 h) cells of fusobacterial strains normalized to an OD600 of ~0.6 in fresh TSPC were seeded into flat-bottom, multi-well plates (Greiner Bio-One) and grown anaerobically for 48 h at 37°C. Obtained biofilms were washed gently in phosphate-buffered saline (PBS) and dried before being stained with 0.2 mL of 1% crystal violet (wt/vol) solution for 10 min at room temperature with gentle shaking. Biofilms were gently washed with sterile water before being dried and imaged. For quantification, dried biofilms were de-stained with acetic acid (30% vol/vol) for 10 min at room temperature, followed by measurement at OD590. Results were obtained from at least three independent experiments performed in triplicate. Statistical analysis was performed by GraphPad Prism 9.0.
Bacterial coaggregation assays
Fusobacterial interaction with bacterial partner strains was assessed using a previously published coaggregation assay (24), with some modifications. Briefly, overnight cultures (~20 h) of F. nucleatum and partner strains (S. oralis, S. gordonii, and A. oris) were harvested by centrifugation and washed twice in coaggregation buffer (0.02 M tris-buffered saline, 150 mM NaCl, 0.1 mM CaCl2). Fusobacterial cells were normalized to an OD600 of ~0.4 in coaggregation buffer without or with 15 mM L-lysine, when indicated, whereas partner strains were normalized to an OD600 of 2.0 in coaggregation buffer. Also, 0.25 mL aliquots of normalized fusobacterial and partner strains were mixed in multi-well plates (GenClone), and coaggregation was imaged. For the experiments using unwashed fusobacterial cells, a similar procedure was used, except that fusobacterial cultures were directly used without washing. All coaggregation assays were performed in an aerated condition. Results were obtained from at least three independent experiments performed in triplicate.
H2S detection
Detection of H2S was performed according to a published protocol with slight modification (25). Briefly, overnight cultures (~20 h) of fusobacterial cells were normalized to an OD600 of ~0.6 in TSPC, and 0.1 mL of normalized cell suspension was mixed with 0.1 mL of bismuth solution (0.4 M triethanolamine pH 8.0, 10 mM bismuth chloride, 20 mM pyridoxal 5-phosphate monohydride, 20 mM EDTA, 40 mM L-cysteine) and incubated at 37°C anaerobic for 1 h, at which point, images were taken and H2S was quantified by OD405. The results were presented as average of at least three independent experiments performed in triplicate.
Measurement of lysine levels by liquid chromatography-mass spectrometry
The relative lysine levels from the culture supernatant of various fusobacterial strains grown to a stationary phase (~20 h) were determined at the Metabolomics Core at Baylor College of Medicine, according to our previous publication (24). Significance analysis was performed by GraphPad Prism.
ATP quantification assay
Mid-log phase fusobacterial cells (OD600 of ~0.5) were harvested by centrifugation and combined in equal volumes (0.1 mL) with the BacTiter-Glo Reagent (Promega) in multi-well plates (Cellstar). The plates were incubated at room temperature in dark for ~2 min prior to measurement of relative luminescent unit using a plate reader (Tecan). ATP concentrations were determined from an ATP standard curve with ATP concentrations ranging from 1 nM to 1,000 nM. The results, presented as pmol/106 CFU, were obtained from at least three independent experiments performed in triplicate.
Quantification of CFU
For the ATP quantification assay, aliquots (0.1 mL) of fusobacterial cells harvested at mid-log phase and normalized to OD600 of 0.5 were serially diluted (100–10−7) in a 96-well plate before spot plating 10 µL on TSPC agar plates supplemented with 5 µg/mL thiamphenicol when required. Plates were incubated in an anaerobic chamber at 37°C for 2 days before quantification. ATP levels of fusobacterial strains were normalized by their respective calculated CFU/mL. For CFU quantification over a 24-h growth period, stationary phase (~20 h) fusobacterial cultures were used to inoculate fresh cultures with starting OD600 of 0.1. Aliquots (0.1 mL) were taken at 8.5, 15, and 24 h of growth for spot plating and CFU/mL analysis. Results were obtained from three independent experiments performed in triplicate.
Western blotting
Expression of fusobacterial proteins was analyzed by immunoblotting with antibodies against RadD (α-RadD; 1:5,000), MegL (α-MegL; 1:5,000), FtsX (α-FtsX; 1:2,000), and RnfC (α-RnfC; 1:3,000). Generation of the first three antibodies was described elsewhere (24–26). For α-RnfC, the procedure was followed according to a previously published protocol (26). Briefly, E. coli BL21 (DE3) harboring pMCSG7-RnfC was used to purify recombinant protein RnfC by affinity chromatography. The purified protein was used for antibody production (Cocalico Biologicals, Inc.). For immunoblotting, overnight fusobacterial cultures were normalized to an OD600 of 1.0, and 1 mL aliquots of bacterial cultures were taken for trichloroacetic acid precipitation and acetone wash, as previously reported (24). Protein samples obtained were suspended in SDS-containing sample buffer, separated by SDS-PAGE using 4%–15% Tris-Glycine gradient gels (RadD and MegL) or a 12% Tris-Glycine gel (RnfC), and immunoblotted by specific antibodies.
Electron microscopy
Electron microscopy was performed according to previously published protocols (24, 26). Briefly, overnight cultures of fusobacteria were harvested by centrifugation and re-suspended in PBS supplemented with 0.1 M NaCl. A drop of bacterial suspension was added to carbon-coated grids, stained with 1% uranyl acetate, and washed prior to imaging with an electron microscope (JEOL 1200).
Immunofluorescence microscopy
Overnight-grown (~20 h) fusobacterial cells were harvested by centrifugation and washed twice in PBS before normalizing to an OD600 of 0.5 in PBS. Also, 0.2 mL aliquots of cell suspension were used to coat circular glass coverslips placed in a 24-well plate for 20 min at room temperature. Cells were fixed with 2.5% formaldehyde (in PBS) for 20 min, washed with PBS, and blocked with 3% wt/vol bovine serum albumin for 1 h. Cells were incubated with α-RadD (1:200) for 1 h and then AlexaFluor 488 goat anti-rabbit IgG for another hour, followed by washing in PBS three times in the dark. Coverslips were mounted on glass slides with VECTASHIELD anti-fade mounting medium with DAPI (Vector Laboratories, Inc.). Cells were analyzed by a fluorescence microscope (Keyence BZ-X800).
Targeted metabolic analysis
Parent and ΔrnfC mutant cells were harvested by centrifugation from mid-log phase cultures in triplicate and normalized to an OD600 of 0.5 before drying in a speed vacuum concentrator (Thermo Scientific). Dried pellet samples were subjected to metabolomics analysis at the UC Riverside Metabolomics Core Facility as previously described with some modifications (48). In brief, 10 mg of dry pellet was extracted with 100 µL/mg of monophasic extraction solvent (30:30:20:20/acetonitrile, methanol, isopropanol, and water) by sonication on ice for 5 min, followed by 90-min vortexing at 4°C. Cell-free supernatants were collected by centrifugation (3,000 g) at 4°C for 30 min, and 1 mL aliquots were analyzed by a TQ-XS triple quadrupole mass spectrometer (Waters) coupled to an I-class UPLC system (Waters), with separations performed using a ZIC-pHILIC column (2.1 × 150 mm, 5 µM) (EMD Millipore). The mobile phases were (A) water supplemented with 15 mM ammonium bicarbonate titrated to a pH of 9.6 with ammonium hydroxide and (B) acetonitrile. The flow rate was 200 µL/min, and the columns were held at 50°C. The injection volume was 2 µL. The gradient was as follows: 0 min, 90% B; 1.5 min, 90% B; 16 min, 20% B; 18 min, 20% B; 20 min, 90% B; 28 min, 90% B. The MS was operated in multiple-reaction monitoring mode. Source and desolvation temperatures were 150°C and 600°C, respectively. Desolvation gas was set to 1,100 L/h and cone gas to 150 L/h. Collision gas was set to 0.15 mL/min. All gases were nitrogen except the collision gas of argon. Capillary voltage was 1 kV in positive ion mode and 2 kV in negative ion mode. Four quality control (QC) samples, generated by pooling equal aliquots of each sample, were analyzed periodically to monitor system stability and performance. Samples were analyzed in random order. Statistical analysis was performed relative to the parent strain and determined by a Student’s t-test, using GraphPad Prism 9.0.
Raw mass spectral data for all 81 identified metabolites with corresponding Kyoto Encyclopedia of Genes and Genomes (KEGG) identifiers above for F. nucleatum ATCC 23726 were used to perform quantitative enrichment and pathway analysis using MetaboAnalyst 5.0 (49, 50). Statistical analysis was performed relative to the parent strain and determined by the global test of MetaboAnalyst 5.0. The raw metabolomic data can be accessed from Github with the following link: https://github.com/Timbritton7/RawMetabolomicAnalysis_Britton.git.
Mouse model of preterm birth
The virulence potential of ΔrnfC was evaluated using a published mouse model of preterm birth (25, 37). Briefly, groups of five CF-1 (Charles River Laboratories) pregnant mice were infected with ~5 × 107 CFU of the parent or ∆rnfC strain at day 16 or 17 of gestation via tail vein injection. Pup survival was recorded for the next 7 days. Statistical analysis was determined via the Mantel-Cox text, using GraphPad Prism 9.0, and specified in corresponding figure legends.
ACKNOWLEDGMENTS
We thank Amancio De Souza (Metabolomics Core Facility, UCR) for technical assistance and our lab members for their discussion and critical review of the manuscript.
Research reported in this publication was supported by the National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health under award numbers DE030895 (to C.W.) and DE026758 (to H.T.-T). T.A.B. was supported by the UCLA Dentist-Scientist and Oral Health-Researcher Training Program, NIDCR grant T90DE030860. D.F. was supported by the Ruth L. Kirschstein National Research Service Award (T32AI007323). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
T.A.B. and H.T.-T. designed research; T.A.B., C.W., Y.-W.C., D.F., Y.C., M.I.C., and T.T.L. performed research; T.A.B., C.W., Y.-W.C., and A.D. analyzed data; and T.A.B., A.D., and H.T.-T. wrote the paper.
Contributor Information
Hung Ton-That, Email: htonthat@dentistry.ucla.edu.
Indranil Biswas, The University of Kansas Medical Center, Kansas City, Kansas, USA.
Ozlem Yilmaz, Medical University of South Carolina, Charleston, South Carolina, USA.
ETHICS APPROVAL
All animal procedures were approved by the UCLA Animal Research Committee (#ARC-2018–077).
SUPPLEMENTAL MATERIAL
The following material is available online at https://doi.org/10.1128/mbio.01751-23.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
REFERENCES
- 1. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu W-H, Lakshmanan A, Wade WG. 2010. The human oral microbiome. J Bacteriol 192:5002–5017. doi: 10.1128/JB.00542-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Caselli E, Fabbri C, D’Accolti M, Soffritti I, Bassi C, Mazzacane S, Franchi M. 2020. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiol 20:120. doi: 10.1186/s12866-020-01801-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Kolenbrander PE, Andersen RN, Moore LV. 1989. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect Immun 57:3194–3203. doi: 10.1128/iai.57.10.3194-3203.1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Lancy P, Dirienzo JM, Appelbaum B, Rosan B, Holt SC. 1983. Corncob formation between Fusobacterium nucleatum and Streptococcus sanguis. Infect Immun 40:303–309. doi: 10.1128/iai.40.1.303-309.1983 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Coppenhagen-Glazer S, Sol A, Abed J, Naor R, Zhang X, Han YW, Bachrach G. 2015. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth. Infect Immun 83:1104–1113. doi: 10.1128/IAI.02838-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Mutha NVR, Mohammed WK, Krasnogor N, Tan GYA, Choo SW, Jakubovics NS. 2018. Transcriptional responses of Streptococcus gordonii and Fusobacterium nucleatum to coaggregation. Mol Oral Microbiol 33:450–464. doi: 10.1111/omi.12248 [DOI] [PubMed] [Google Scholar]
- 7. Wu T, Cen L, Kaplan C, Zhou X, Lux R, Shi W, He X. 2015. Cellular components mediating coadherence of Candida albicans and Fusobacterium nucleatum. J Dent Res 94:1432–1438. doi: 10.1177/0022034515593706 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS. 2003. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 11:94–100. doi: 10.1016/s0966-842x(02)00034-3 [DOI] [PubMed] [Google Scholar]
- 9. Kolenbrander PE, Andersen RN. 1989. Inhibition of coaggregation between Fusobacterium nucleatum and Porphyromonas (Bacteroides) gingivalis by lactose and related sugars. Infect Immun 57:3204–3209. doi: 10.1128/iai.57.10.3204-3209.1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Karched M, Bhardwaj RG, Asikainen SE. 2015. Coaggregation and biofilm growth of granulicatella spp. with Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans. BMC Microbiol 15:114. doi: 10.1186/s12866-015-0439-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Polak D, Shapira L, Weiss EI, Houri-Haddad Y. 2012. The role of coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection. J Clin Periodontol 39:617–625. doi: 10.1111/j.1600-051X.2012.01889.x [DOI] [PubMed] [Google Scholar]
- 12. Yamaguchi-Kuroda Y, Kikuchi Y, Kokubu E, Ishihara K. 2023. Porphyromonas gingivalis diffusible signaling molecules enhance Fusobacterium nucleatum biofilm formation via gene expression modulation. J Oral Microbiol 15:2165001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Han YW, Shen T, Chung P, Buhimschi IA, Buhimschi CS. 2009. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol 47:38–47. doi: 10.1128/JCM.01206-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Payne MS, Bayatibojakhi S. 2014. Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome. Front Immunol 5:595. doi: 10.3389/fimmu.2014.00595 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, Nissan A, Sandbank J, Yehuda-Shnaidman E, Ponath F, Vogel J, Mandelboim O, Granot Z, Straussman R, Bachrach G. 2020. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun 11:3259. doi: 10.1038/s41467-020-16967-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Udayasuryan B, Ahmad RN, Nguyen TTD, Umaña A, Monét Roberts L, Sobol P, Jones SD, Munson JM, Slade DJ, Verbridge SS. 2022. Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling. Sci Signal 15:eabn4948. doi: 10.1126/scisignal.abn4948 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. 2013. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14:195–206. doi: 10.1016/j.chom.2013.07.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Abed J, Emgård JEM, Zamir G, Faroja M, Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA, Mellul A, Chaushu S, Manson AL, Earl AM, Ou N, Brennan CA, Garrett WS, Bachrach G. 2016. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed gal-GaLNAc. Cell Host Microbe 20:215–225. doi: 10.1016/j.chom.2016.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Parhi L, Abed J, Shhadeh A, Alon-Maimon T, Udi S, Ben-Arye SL, Tam J, Parnas O, Padler-Karavani V, Goldman-Wohl D, Yagel S, Mandelboim O, Bachrach G. 2022. Placental colonization by Fusobacterium nucleatum is mediated by binding of the Fap2 lectin to placentally displayed Gal-GaLNAc. Cell Rep 38:110537. doi: 10.1016/j.celrep.2022.110537 [DOI] [PubMed] [Google Scholar]
- 20. Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, Dalerba P, Wang TC, Han YW. 2019. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/beta-catenin modulator annexin A1. EMBO Rep 20:e47638. doi: 10.15252/embr.201847638 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Xu M, Yamada M, Li M, Liu H, Chen SG, Han YW. 2007. FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cells. J Biol Chem 282:25000–25009. doi: 10.1074/jbc.M611567200 [DOI] [PubMed] [Google Scholar]
- 22. Ikegami A, Chung P, Han YW. 2009. Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed Adhesin promotes cellular invasion and placental colonization. Infect Immun 77:3075–3079. doi: 10.1128/IAI.00209-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Kaplan CW, Lux R, Haake SK, Shi W. 2009. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol Microbiol 71:35–47. doi: 10.1111/j.1365-2958.2008.06503.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Wu C, Chen Y-W, Scheible M, Chang C, Wittchen M, Lee JH, Luong TT, Tiner BL, Tauch A, Das A, Ton-That H. 2021. Genetic and molecular determinants of polymicrobial interactions in Fusobacterium nucleatum. Proc Natl Acad Sci U S A 118:e2006482118. doi: 10.1073/pnas.2006482118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Chen Y-W, Camacho MI, Chen Y, Bhat AH, Chang C, Peluso EA, Wu C, Das A, Ton-That H. 2022. Genetic determinants of hydrogen sulfide biosynthesis in Fusobacterium Nucleatum are required for bacterial fitness, antibiotic sensitivity, and virulence. mBio 13:e0193622. doi: 10.1128/mbio.01936-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Wu C, Al Mamun AAM, Luong TT, Hu B, Gu J, Lee JH, D’Amore M, Das A, Ton-That H. 2018. Forward genetic dissection of biofilm development by Fusobacterium nucleatum: novel functions of cell division proteins FtsX and EnvC. mBio 9:e00360-18. doi: 10.1128/mBio.00360-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Schmehl M, Jahn A, Meyer zu Vilsendorf A, Hennecke S, Masepohl B, Schuppler M, Marxer M, Oelze J, Klipp W. 1993. Identification of a new class of nitrogen fixation genes in Rhodobacter capsulatus: a putative membrane complex involved in electron transport to nitrogenase. Mol Gen Genet 241:602–615. doi: 10.1007/BF00279903 [DOI] [PubMed] [Google Scholar]
- 28. Reyes-Prieto A, Barquera B, Juárez O. 2014. Origin and evolution of the sodium -pumping NADH: ubiquinone oxidoreductase. PLoS One 9:e96696. doi: 10.1371/journal.pone.0096696 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Biegel E, Müller V. 2010. Bacterial Na+-translocating ferredoxin:NAD+ oxidoreductase. Proc Natl Acad Sci U S A 107:18138–18142. doi: 10.1073/pnas.1010318107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Biegel E, Schmidt S, Müller V. 2009. Genetic, immunological and biochemical evidence for a Rnf complex in the acetogen Acetobacterium woodii. Environ Microbiol 11:1438–1443. doi: 10.1111/j.1462-2920.2009.01871.x [DOI] [PubMed] [Google Scholar]
- 31. Neumann-Schaal M, Jahn D, Schmidt-Hohagen K. 2019. Metabolism the difficile way: the key to the success of the pathogen Clostridioides difficile. Front Microbiol 10:219. doi: 10.3389/fmicb.2019.00219 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Weghoff MC, Bertsch J, Müller V. 2015. A novel mode of lactate metabolism in strictly anaerobic bacteria. Environ Microbiol 17:670–677. doi: 10.1111/1462-2920.12493 [DOI] [PubMed] [Google Scholar]
- 33. Seedorf H, Fricke WF, Veith B, Brüggemann H, Liesegang H, Strittmatter A, Miethke M, Buckel W, Hinderberger J, Li F, Hagemeier C, Thauer RK, Gottschalk G. 2008. The genome of Clostridium kluyveri, a strict anaerobe with unique metabolic features. Proc Natl Acad Sci U S A 105:2128–2133. doi: 10.1073/pnas.0711093105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Hreha TN, Mezic KG, Herce HD, Duffy EB, Bourges A, Pryshchep S, Juarez O, Barquera B. 2015. Complete topology of the RNF complex from Vibrio cholerae. Biochemistry 54:2443–2455. doi: 10.1021/acs.biochem.5b00020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Koo MS, Lee JH, Rah SY, Yeo WS, Lee JW, Lee KL, Koh YS, Kang SO, Roe JH. 2003. A reducing system of the superoxide sensor SoxR in Escherichia coli . EMBO J 22:2614–2622. doi: 10.1093/emboj/cdg252 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Liu Y, Chen H, Van Treuren W, Hou B-H, Higginbottom SK, Dodd D. 2022. Clostridium sporogenes uses reductive stickland metabolism in the gut to generate ATP and produce circulating metabolites. Nat Microbiol 7:695–706. doi: 10.1038/s41564-022-01109-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Peluso EA, Scheible M, Ton-That H, Wu C. 2020. Genetic manipulation and virulence assessment of Fusobacterium nucleatum. Curr Protoc Microbiol 57:e104. doi: 10.1002/cpmc.104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Biegel E, Schmidt S, González JM, Müller V. 2011. Biochemistry, evolution and physiological function of the Rnf complex, a novel ion-motive electron transport complex in prokaryotes. Cell Mol Life Sci 68:613–634. doi: 10.1007/s00018-010-0555-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Tremblay P-L, Zhang T, Dar SA, Leang C, Lovley DR, Newman DK. 2013. The Rnf complex of Clostridium ljungdahlii is a proton-translocating ferredoxin:NAD+ oxidoreductase essential for autotrophic growth. mBio 4:e00406-12. doi: 10.1128/mBio.00406-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Dzink JL, Socransky SS. 1990. Amino acid utilization by Fusobacterium nucleatum grown in a chemically defined medium. Oral Microbiol Immunol 5:172–174. doi: 10.1111/j.1399-302x.1990.tb00418.x [DOI] [PubMed] [Google Scholar]
- 41. Fukamachi H, Nakano Y, Yoshimura M, Koga T. 2002. Cloning and characterization of the L-cysteine desulfhydrase gene of Fusobacterium nucleatum. FEMS Microbiol Lett 215:75–80. doi: 10.1111/j.1574-6968.2002.tb11373.x [DOI] [PubMed] [Google Scholar]
- 42. Yoshida Y, Suwabe K, Nagano K, Kezuka Y, Kato H, Yoshimura F. 2011. Identification and enzymic analysis of a novel protein associated with production of hydrogen sulfide and L-serine from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586. Microbiology (Reading) 157:2164–2171. doi: 10.1099/mic.0.048934-0 [DOI] [PubMed] [Google Scholar]
- 43. Yoshida Y, Ito S, Kamo M, Kezuka Y, Tamura H, Kunimatsu K, Kato H. 2010. Production of hydrogen sulfide by two enzymes associated with biosynthesis of homocysteine and lanthionine in Fusobacterium nucleatum subsp. Microbiology (Reading) 156:2260–2269. doi: 10.1099/mic.0.039180-0 [DOI] [PubMed] [Google Scholar]
- 44. Suwabe K, Yoshida Y, Nagano K, Yoshimura F. 2011. Identification of an L-methionine gamma-lyase involved in the production of hydrogen sulfide from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586. Microbiology (Reading) 157:2992–3000. doi: 10.1099/mic.0.051813-0 [DOI] [PubMed] [Google Scholar]
- 45. Vasstrand EN, Hofstad T, Endresen C, Jensen HB. 1979. Demonstration of lanthionine as a natural constituent of the peptidoglycan of Fusobacterium nucleatum. Infect Immun 25:775–780. doi: 10.1128/iai.25.3.775-780.1979 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Fredriksen A, Vasstrand EN, Jensen HB. 1991. Peptidoglycan precursor from Fusobacterium nucleatum contains lanthionine. J Bacteriol 173:900–902. doi: 10.1128/jb.173.2.900-902.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Siegel SD, Amer BR, Wu C, Sawaya MR, Gosschalk JE, Clubb RT, Ton-That H. 2019. Structure and mechanism of LcpA, a phosphotransferase that mediates glycosylation of a gram-positive bacterial cell wall-anchored protein. mBio 10:e01580-18. doi: 10.1128/mBio.01580-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Vliet SMF, Dasgupta S, Sparks NRL, Kirkwood JS, Vollaro A, Hur M, Zur Nieden NI, Volz DC. 2019. Maternal-to-zygotic transition as a potential target for niclosamide during early embryogenesis. Toxicol Appl Pharmacol 380:114699. doi: 10.1016/j.taap.2019.114699 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Xia J, Psychogios N, Young N, Wishart DS. 2009. Metaboanalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37:W652–60. doi: 10.1093/nar/gkp356 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Pang Z, Zhou G, Ewald J, Chang L, Hacariz O, Basu N, Xia J. 2022. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc 17:1735–1761. doi: 10.1038/s41596-022-00710-w [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.